Literature DB >> 30461368

Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43.

Poulomee Bose1, Gary A B Armstrong2, Pierre Drapeau1.   

Abstract

Almost 90% of amyotrophic lateral sclerosis (ALS) cases are characterized by the presence of aggregates of insoluble, misfolded cytoplasmic TAR DNA binding protein of 43 kDa (TDP-43). Distal axonopathy with impaired neuromuscular junctions (NMJs) before motor neuron degeneration or clinical onset of symptoms has been hypothesized as an early pathology in ALS. However, synaptic defects at the NMJ caused by TDP-43 mutations have not been characterized. In this study, we examined a previously reported zebrafish line expressing the tardbpY220X/Y220X variant, which results in an unstable and degraded protein. These tardbp-/- larvae, however, mature normally due to the upregulated expression of an alternative splice variant of the tardbp paralog tardbp-like, or tardbpl. We generated a mutant line with a CRISPR/Cas9-mediated 5-base pair deletion encompassing the ATG start codon of tardbpl and in-crossed these with tardbp-/- mutants to obtain tardbp-/- and tardbpl-/- double mutants, herein referred to as hom/hom. We subsequently characterized morphological, coiling, locomotor, synaptic, and NMJ structural abnormalities in the hom/hom mutants and in their genotypic controls. We observed that hom/hom mutants displayed gross morphological defects, early lethality, reduced locomotor function, aberrant quantal transmission, and perturbed synapse architecture at the NMJ. We further employed pharmacological manipulations in an effort to rescue phenotypic defects and observed that tardbp+/-; tardbpl-/- (herein referred to as het/hom) mutants, but not hom/hom mutants, were sensitive to chronic treatments of BAY K 8644, an L-type calcium channel agonist. This result highlights the importance of partial vs. complete loss of allelic functions of TDP-43. NEW & NOTEWORTHY This study highlights the importance of partial vs. complete loss of allelic functions of TDP-43 in a zebrafish loss of function model, thus making it an attractive tool for drug screening approaches.

Entities:  

Keywords:  ALS; NMJ; TDP-43; zebrafish

Mesh:

Substances:

Year:  2018        PMID: 30461368     DOI: 10.1152/jn.00265.2018

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  9 in total

1.  Presynaptic Homeostasis Opposes Disease Progression in Mouse Models of ALS-Like Degeneration: Evidence for Homeostatic Neuroprotection.

Authors:  Brian O Orr; Anna G Hauswirth; Barbara Celona; Richard D Fetter; Giulia Zunino; Evgeny Z Kvon; Yiwen Zhu; Len A Pennacchio; Brian L Black; Graeme W Davis
Journal:  Neuron       Date:  2020-05-06       Impact factor: 17.173

Review 2.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

3.  CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo.

Authors:  Philipp Voisard; Federica Diofano; Amelia A Glazier; Wolfgang Rottbauer; Steffen Just
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

4.  Bioengineered model of the human motor unit with physiologically functional neuromuscular junctions.

Authors:  Rowan P Rimington; Jacob W Fleming; Andrew J Capel; Patrick C Wheeler; Mark P Lewis
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

5.  Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR.

Authors:  Angeles Edith Espino-Saldaña; Roberto Rodríguez-Ortiz; Elizabeth Pereida-Jaramillo; Ataúlfo Martínez-Torres
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 6.  Illuminating ALS Motor Neurons With Optogenetics in Zebrafish.

Authors:  Kazuhide Asakawa; Hiroshi Handa; Koichi Kawakami
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 7.  The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis.

Authors:  Jinmeng Liu; Fenghua Zhou; Yingjun Guan; Fandi Meng; Zhenhan Zhao; Qi Su; Weiwei Bao; Xuemei Wang; Jiantao Zhao; Zijun Huo; Lingyun Zhang; Shuanhu Zhou; Yanchun Chen; Xin Wang
Journal:  Cells       Date:  2022-02-07       Impact factor: 6.600

Review 8.  Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis.

Authors:  Poulomee Bose
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

Review 9.  Friend or Foe? The Varied Faces of Homeostatic Synaptic Plasticity in Neurodegenerative Disease.

Authors:  Henry B C Taylor; Alexander F Jeans
Journal:  Front Cell Neurosci       Date:  2021-12-10       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.